GRI Bio Capital Expenditures (CapEx) Growth & History (GRI)

GRI Bio's capital expenditures (capex) was $3,000 for fiscal 2025.

View full GRI Bio company overview

GRI Bio annual capital expenditures (capex) history

GRI Bio annual capital expenditures (capex)

Fiscal yearPeriod endedCapital expenditures (CapEx)ChangeGrowth
20252025-12-31$3,000$3,000
20242024-12-31$0−$8,000
20232023-12-31$8,000$5,000+166.67%
20222022-12-31$3,000$3,000
20212021-12-31$0−$2,000
20202020-12-31$2,000

GRI Bio capital expenditures (capex) trends

Over the last five fiscal years, GRI Bio's capital expenditures (capex) increased from $2,000 to $3,000, a change of $1,000. The latest reported quarter, Q3 2024, shows $0.

About the metric

What capital expenditures (CapEx) mean

Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.

Calculation and source

SEC-reported capital expenditures

TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review GRI Bio source filings ↗

Community posts

It’s quiet here.

No posts about GRI yet. Start the conversation.

Write the first post